The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus.
J. Nesselhut
No relevant relationships to disclose
D. Marx
No relevant relationships to disclose
D. Lorenzen
No relevant relationships to disclose
N. Cillien
No relevant relationships to disclose
W. Goebel
No relevant relationships to disclose
R. Y. Chang
No relevant relationships to disclose
W. Brockmann
No relevant relationships to disclose
J. H. Peters
No relevant relationships to disclose
K. Nesselhut
No relevant relationships to disclose
F. Fändrich
No relevant relationships to disclose
T. Nesselhut
No relevant relationships to disclose